253 related articles for article (PubMed ID: 10182705)
1. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(170):46718. PubMed ID: 10182705
[TBL] [Abstract][Full Text] [Related]
2. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
[TBL] [Abstract][Full Text] [Related]
3. Biological products regulated under Section 351 of the Public Health Service Act; implementation of biologics license; elimination of establishment license and product license; public workshop--FDA. Proposed rule; notice of workshop.
Fed Regist; 1998 Aug; 63(154):42773-4. PubMed ID: 10182565
[TBL] [Abstract][Full Text] [Related]
4. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Nov; 63(228):65566. PubMed ID: 10338876
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Direct final rule; correction.
Fed Regist; 1998 Nov; 63(228):65554-5. PubMed ID: 10338874
[TBL] [Abstract][Full Text] [Related]
7. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(184):50815. PubMed ID: 10185805
[TBL] [Abstract][Full Text] [Related]
8. Revisions to the general safety test requirements for biological products--FDA. Direct final rule: confirmation in part and withdrawal in part.
Fed Regist; 1998 Aug; 63(150):41718. PubMed ID: 10181723
[TBL] [Abstract][Full Text] [Related]
9. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule.
Fed Regist; 1998 May; 63(93):26744-55. PubMed ID: 10179343
[TBL] [Abstract][Full Text] [Related]
10. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
[TBL] [Abstract][Full Text] [Related]
11. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period.
Fed Regist; 1998 Dec; 63(237):68212-3. PubMed ID: 10338885
[TBL] [Abstract][Full Text] [Related]
12. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration; correction--FDA. Tentative final rule; correction.
Fed Regist; 1992 Feb; 57(37):6486-7. PubMed ID: 10117356
[TBL] [Abstract][Full Text] [Related]
14. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
[TBL] [Abstract][Full Text] [Related]
15. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
[TBL] [Abstract][Full Text] [Related]
16. Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(75):19431-4. PubMed ID: 10178870
[TBL] [Abstract][Full Text] [Related]
17. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2001 Jan; 66(13):5447-69. PubMed ID: 11503777
[TBL] [Abstract][Full Text] [Related]
18. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
[TBL] [Abstract][Full Text] [Related]
19. Financial disclosure by clinical investigators; correction--FDA. Final rule; correction.
Fed Regist; 1998 Jun; 63(124):35134. PubMed ID: 10180634
[TBL] [Abstract][Full Text] [Related]
20. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring--FDA. Proposed rule.
Fed Regist; 1998 May; 63(99):28301-9. PubMed ID: 10179873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
